Literature DB >> 26011643

Focused antibody response to influenza linked to antigenic drift.

Kuan-Ying A Huang, Pramila Rijal, Lisa Schimanski, Timothy J Powell, Tzou-Yien Lin, John W McCauley, Rodney S Daniels, Alain R Townsend.   

Abstract

The selective pressure that drives antigenic changes in influenza viruses is thought to originate from the human immune response. Here, we have characterized the B cell repertoire from a previously vaccinated donor whose serum had reduced neutralizing activity against the recently evolved clade 6B H1N1pdm09 viruses. While the response was markedly polyclonal, 88% of clones failed to recognize clade 6B viruses; however, the ability to neutralize A/USSR/90/1977 influenza, to which the donor would have been exposed in childhood, was retained. In vitro selection of virus variants with representative monoclonal antibodies revealed that a single amino acid replacement at residue K163 in the Sa antigenic site, which is characteristic of the clade 6B viruses, was responsible for resistance to neutralization by multiple monoclonal antibodies and the donor serum. The K163 residue lies in a part of a conserved surface that is common to the hemagglutinins of the 1977 and 2009 H1N1 viruses. Vaccination with the 2009 hemagglutinin induced an antibody response tightly focused on this common surface that is capable of selecting current antigenic drift variants in H1N1pdm09 influenza viruses. Moreover, amino acid replacement at K163 was not highlighted by standard ferret antisera. Human monoclonal antibodies may be a useful adjunct to ferret antisera for detecting antigenic drift in influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26011643      PMCID: PMC4613558          DOI: 10.1172/JCI81104

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  65 in total

1.  A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore.

Authors:  I G Barr; L Cui; N Komadina; R T Lee; R T Lin; Y Deng; N Caldwell; R Shaw; S Maurer-Stroh
Journal:  Euro Surveill       Date:  2010-10-21

2.  Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003.

Authors:  Jun Okada; Nobuko Ohshima; Ritsuko Kubota-Koketsu; Sayuri Ota; Wakana Takase; Masachika Azuma; Yoshitaka Iba; Naoko Nakagawa; Tetsushi Yoshikawa; Youichi Nakajima; Toyokazu Ishikawa; Yoshizo Asano; Yoshinobu Okuno; Yoshikazu Kurosawa
Journal:  Virology       Date:  2009-12-06       Impact factor: 3.616

Review 3.  Modulation by epitope-specific antibodies of class II MHC-restricted presentation of the tetanus toxin antigen.

Authors:  C Watts; A Antoniou; B Manoury; E W Hewitt; L M Mckay; L Grayson; N F Fairweather; P Emsley; N Isaacs; P D Simitsek
Journal:  Immunol Rev       Date:  1998-08       Impact factor: 12.988

4.  Constraints in T-B cooperation related to epitope topology on E. coli beta-galactosidase. I. The fine specificity of T cells dictates the fine specificity of antibodies directed to conformation-dependent determinants.

Authors:  F Manca; A Kunkl; D Fenoglio; A Fowler; E Sercarz; F Celada
Journal:  Eur J Immunol       Date:  1985-04       Impact factor: 5.532

5.  Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.

Authors:  Gui-Mei Li; Christopher Chiu; Jens Wrammert; Megan McCausland; Sarah F Andrews; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Xinyan Qu; Srilatha Edupuganti; Mark Mulligan; Suman R Das; Jonathan W Yewdell; Aneesh K Mehta; Patrick C Wilson; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

6.  Reconstruction of a pathway of antigen processing and class II MHC peptide capture.

Authors:  Catherine X Moss; Timothy I Tree; Colin Watts
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

7.  Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.

Authors:  Matthew S Miller; Thomas J Gardner; Florian Krammer; Lauren C Aguado; Domenico Tortorella; Christopher F Basler; Peter Palese
Journal:  Sci Transl Med       Date:  2013-08-14       Impact factor: 17.956

8.  Antibody landscapes after influenza virus infection or vaccination.

Authors:  J M Fonville; S H Wilks; S L James; A Fox; M Ventresca; M Aban; L Xue; T C Jones; N M H Le; Q T Pham; N D Tran; Y Wong; A Mosterin; L C Katzelnick; D Labonte; T T Le; G van der Net; E Skepner; C A Russell; T D Kaplan; G F Rimmelzwaan; N Masurel; J C de Jong; A Palache; W E P Beyer; Q M Le; T H Nguyen; H F L Wertheim; A C Hurt; A D M E Osterhaus; I G Barr; R A M Fouchier; P W Horby; D J Smith
Journal:  Science       Date:  2014-11-21       Impact factor: 47.728

9.  Structural assignment of novel and immunodominant antigenic sites in the neutralizing antibody response of CBA/Ca mice to influenza hemagglutinin.

Authors:  C A Smith; B C Barnett; D B Thomas; F Temoltzin-Palacios
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

10.  Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice.

Authors:  L M Staudt; W Gerhard
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  62 in total

Review 1.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

2.  Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.

Authors:  Seth J Zost; Nicholas C Wu; Scott E Hensley; Ian A Wilson
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

3.  Age-specific effects of vaccine egg adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination.

Authors:  Feng Liu; F Liaini Gross; Stacie N Jefferson; Crystal Holiday; Yaohui Bai; Li Wang; Bin Zhou; Min Z Levine
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

4.  Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.

Authors:  Danuta M Skowronski; Catharine Chambers; Gaston De Serres; Suzana Sabaiduc; Anne-Luise Winter; James A Dickinson; Jonathan B Gubbay; Kevin Fonseca; Steven J Drews; Hugues Charest; Christine Martineau; Mel Krajden; Martin Petric; Nathalie Bastien; Yan Li; Derek J Smith
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

5.  Flu Vaccine-Too Much of a Good Thing?

Authors:  John Treanor
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

6.  Influenza vaccination and the 'diversity paradox'.

Authors:  Craig P Thompson; Uri Obolski
Journal:  Hum Vaccin Immunother       Date:  2018-09-21       Impact factor: 3.452

7.  Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.

Authors:  Erica Ollmann Saphire; Sharon L Schendel; Marnie L Fusco; Karthik Gangavarapu; Bronwyn M Gunn; Anna Z Wec; Peter J Halfmann; Jennifer M Brannan; Andrew S Herbert; Xiangguo Qiu; Kshitij Wagh; Shihua He; Elena E Giorgi; James Theiler; Kathleen B J Pommert; Tyler B Krause; Hannah L Turner; Charles D Murin; Jesper Pallesen; Edgar Davidson; Rafi Ahmed; M Javad Aman; Alexander Bukreyev; Dennis R Burton; James E Crowe; Carl W Davis; George Georgiou; Florian Krammer; Christos A Kyratsous; Jonathan R Lai; Cory Nykiforuk; Michael H Pauly; Pramila Rijal; Ayato Takada; Alain R Townsend; Viktor Volchkov; Laura M Walker; Cheng-I Wang; Larry Zeitlin; Benjamin J Doranz; Andrew B Ward; Bette Korber; Gary P Kobinger; Kristian G Andersen; Yoshihiro Kawaoka; Galit Alter; Kartik Chandran; John M Dye
Journal:  Cell       Date:  2018-08-09       Impact factor: 41.582

8.  Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells.

Authors:  Ramin Sedaghat Herati; Alexander Muselman; Laura Vella; Bertram Bengsch; Kaela Parkhouse; Daniel Del Alcazar; Jonathan Kotzin; Susan A Doyle; Pablo Tebas; Scott E Hensley; Laura F Su; Kenneth E Schmader; E John Wherry
Journal:  Sci Immunol       Date:  2017-02-17

Review 9.  From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

Authors:  Carole Henry; Anna-Karin E Palm; Florian Krammer; Patrick C Wilson
Journal:  Trends Immunol       Date:  2017-08-31       Impact factor: 16.687

10.  Plasticity of Amino Acid Residue 145 Near the Receptor Binding Site of H3 Swine Influenza A Viruses and Its Impact on Receptor Binding and Antibody Recognition.

Authors:  Jefferson J S Santos; Eugenio J Abente; Adebimpe O Obadan; Andrew J Thompson; Lucas Ferreri; Ginger Geiger; Ana S Gonzalez-Reiche; Nicola S Lewis; David F Burke; Daniela S Rajão; James C Paulson; Amy L Vincent; Daniel R Perez
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.